LL-37
Also known as: Cathelicidin, CAP-18 fragment
Molecular Overview
LL-37 is the only human cathelicidin peptide and a widely used reference compound in innate-immunity and antimicrobial-peptide research.
Mechanistic Background
Amphipathic helix that interacts with microbial membranes and host immune receptors in experimental systems.
What Researchers Study
Large peer-reviewed literature across microbiology and immunology.
Evidence Landscape
Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.
Research Limitations
Therapeutic development remains investigational.
Scientific References
Research Use Only
Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.